euro adhoc: Marseille-Kliniken AG / other / - Further real estate deal signed - Sale of six care facilities for EUR 33.5 m

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

30.06.2008

Adhoc Release in accordance with section 15 of the German Securities
Trading Act (WpHG)

Berlin, 30 June 2008. Marseille-Kliniken AG (Prime Standard, ISIN DE
0007783003, MKA) has signed a sale-and-lease-back deal with a
consortium of real estate investors, IMMAC Holding AG, Hamburg, as
well as RP&C International / Public Service Properties Investments
Ltd., London. Marseille-Kliniken AG has agreed a long-term lease for
six care properties with a total of 567 beds with the investor
consortium.

In total, the transaction has a volume of EUR 33.5 m and offers the
company further financial scope to pursue its growth strategy in its
core care business.

About 20% of Marseille-Kliniken AG´s portfolio consists of facilities
it uses itself and about 80% which it has leased to other providers.
The transaction will further reduce the company´s long-term financial
debt.

The outlook for the financial year 2007/2008 dated 8 May 2008 is
being confirmed. The company expects an annual turnover of EUR 233.5
m, an EBIT of EUR 24.0 m and a profit after tax of EUR 18.0 m.

End of adhoc release

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Marseille-Kliniken AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Marseille-Kliniken AG

Axel Hölzer

CEO

Alte Jakobstraße 79/80

10709 Berlin

GERMANY

Tel.: +4930 / 246 32-400

Fax: +4930 / 246 32-401

www.marseille-kliniken.com

or

Hillermann Consulting

Christian Hillermann

Investor Relations for Marseille-Kliniken AG

Poststraße 14/16

20354 Hamburg

GERMANY

Tel.: +4940 / 320 279 10

Fax: +4940 / 320 279 114

www.hillermann-consulting.de

Branche: Pharmaceuticals
ISIN: DE0007783003
WKN: 778300
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse Hamburg / regulated dealing